Skip to content

Debt Repayments at other companies

Scilex Holding Company logo
Scilex Holding CompanySCLX
$6.32M
StoneX Group Inc. logo
StoneX Group Inc.SNEX
$6.3M
TEC
Bio-TechneTECH
$60M+650%
Medtronic logo
MedtronicMDT
$1.77B
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$100K0.0%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$1B+290%

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s debt repayments?
BioSig Technologies, Inc. (STEX) reported debt repayments of $2.01M in Q4 2025.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.